M
Masashi Mizokami
Researcher at Nagoya City University
Publications - 684
Citations - 37168
Masashi Mizokami is an academic researcher from Nagoya City University. The author has contributed to research in topics: Hepatitis B virus & Hepatitis C virus. The author has an hindex of 85, co-authored 650 publications receiving 34868 citations. Previous affiliations of Masashi Mizokami include National Institute of Advanced Industrial Science and Technology & University of Florida.
Papers
More filters
Journal Article
Molecular evolution of hepatitis viruses
Masashi Mizokami,Etsuro Orito +1 more
TL;DR: In this article, methods and models for analytical and quantitative researches on the evolution of hepatitis virus using nucleotide sequences and amino acids of hepatitis viruses are described, and the authors propose a model for the analysis of these sequences.
Journal ArticleDOI
Anti‐viral effects of interferon‐λ3 on hepatitis B virus infection in cell culture
Norie Yamada,Asako Murayama,Masaaki Shiina,Hussein H. Aly,Masashi Iwamoto,Senko Tsukuda,Koichi Watashi,Tomohisa Tanaka,Kohji Moriishi,Hironori Nishitsuji,Masaya Sugiyama,Masashi Mizokami,Kunitada Shimotohno,Masamichi Muramatsu,Kazumoto Murata,Takanobu Kato +15 more
TL;DR: This work aimed to prove the antiviral effects of IFN‐λ3 on hepatitis B virus (HBV) by using an in vitro HBV production and infection system.
Journal ArticleDOI
Screening siRNAs against host glycosylation pathways to develop novel antiviral agents against hepatitis B virus.
Kiyoaki Ito,Kiyohiko Angata,Atsushi Kuno,Akinori Okumura,Kazumasa Sakamoto,Rieko Inoue,Naoko Morita,Koichi Watashi,Takaji Wakita,Yasuhito Tanaka,Masaya Sugiyama,Masashi Mizokami,Masashi Yoneda,Hisashi Narimatsu +13 more
TL;DR: The aim of this study was to identify candidate molecules for the development of novel antiviral agents against HBV using an siRNA screening system targeting the host glycosylation pathway.
Patent
Method for measuring glycoprotein, method for examining liver disease, reagent for quantitative determination of glycoprotein, and glycan-marker glycoprotein as an index for clinical conditions of liver disease
Hisashi Narimatsu,Yuzuru Ikehara,Atsushi Kuno,Maki Sogabe,Yasuhito Tanaka,Masashi Mizokami,Kiyoaki Ito,Shunsuke Matsubara,Chikayuki Tsuruno,Youichi Takahama,Takashi Kagawa,Shinya Nagai +11 more
TL;DR: In this article, the authors proposed a method for measuring a glycan-marker glycoprotein, by which liver disease can be detected with higher accuracy than is possible with conventional methods.
Journal Article
Erratum: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome (Nature Medicine (2005) 11 (791-796))
Takaji Wakita,Thomas Pietschmann,Takanobu Kato,Tomoko Date,Michiko Miyamoto,Zijiang Zhao,Krishna K. Murthy,Anja Habermann,Hans-Georg Kräusslich,Masashi Mizokami,Ralf Bartenschlager,T. Jake Liang +11 more